Friday, March 14, 2014

Data shows vaccine effective for late stage melanoma

REUTERS – Mar. 14, 2014 – Updating data from an ongoing clinical trial of 295 patients with advanced melanoma show the vaccine drug effective in shrinking both tumors directly injected with the vaccine and un-injected tumors. The result indicates the vaccine had the desired effect of triggering the immune system to attack cancer cells elsewhere in the body. Sixty-four percent of the directly injected tumors shrank by half, and 47 percent of the tumors disappeared. Of the un-injected tumors, 34 percent shrank by at least half, and 21 percent of those disappeared.  The findings were presented at the Society of Surgical Oncology Cancer Symposium in Phoenix.

No comments:

Post a Comment